Live Breaking News & Updates on Healthnow New York

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and .
Interpace Biosciences, Inc.January 20, 2021 GMT
Third Quarter Net Revenue of $8.2 Million Up 7% vs Prior Year; Third Quarter Year to Date Net Revenue of $22.8 Million Up 14% vs Prior Year
Estimates Fourth Quarter Net Revenue range of $9.0 million - $10.0 million
Realized Reimbursement on Higher ThyGeNEXT Pricing in January
Closed $5 Million Bridge Loan Agreement with Existing Private Equity Investors and terminated the SVB credit facility
Cash balance as of January 15, 2021 was $6.1 million net of restricted cash
Conference Call and Webcast Thursday January 21, 2021 at 4:30 pm ET ....

New York , United States , New Jersey , North Carolina , Interpace Biosciences , Megan Paul , Interpace Bioscience , Fred Knechtel , Thomas Burnell , Silicon Valley Bank , Company Nasdaq , Number International , Edison Group , Interpace Biosciences Inc , Interpace Pharma Solutions , Securities Exchange , Third Quarter Net Revenue , Prior Year , Third Quarter Year , Date Net Revenue , Fourth Quarter Net Revenue , Bridge Loan Agreement , Existing Private Equity Investors , Webcast Thursday January , Ampersand Capital Partners , Third Quarter ,